Ria Purandare
💉Merck digs deeper into ADCs; Vertex boosts immunology pipeline; J&J buys Shockwave
#512 | Heat alert for East Asia; AI for Africa; Vaccine for UTIs
Read More
💉Merck digs deeper into ADCs; Vertex boosts immunology pipeline; J&J buys Shockwave
#512 | Heat alert for East Asia; AI for Africa; Vaccine for UTIs
Read More
💉 Gingko Bio becomes Gingko Buyo; Ipsen enters the ADC race; Bird flu enters the conversation, again
#511 | A clinical trial for Lassa fever; A polio vaccine shortage for India; New hope against autoimmune conditions
Read More
💉 AbbVie gets into colitis, Novo Nordisk digs deeper into cardio, Go West! To Pharmaconex
#510 | Guess who’s back? It’s dengue; Guess who never went away? It’s mpox; AI designs antibodies
Read More
💉 AstraZeneca puts in $2 billion on radiopharma; Novo goes big in China; Merck bets big on Korea
#509 | Novartis’ big aims for Singapore; AbbVie bets on IBD; A future without babies
Read More
💉 AstraZeneca invests in rare diseases; Novartis hopes to take the STING out; Merck bets on smart biologics
#508 | Bird flu jumps species; Ending the gender gap in wifi; Milk for diabetes
Read MoreLuptatum sensibus
Cu qui sed at legere summo mel summo populo inciderint omittantur vel everti no. Id nam possim corrumpit qui admodum.